Concurrently, patients with depression commonly exhibit chronic low-grade inflammation, characterized by persistently elevated pro-inflammatory cytokines [e.g., interleukin-6 (IL-6), Tumor Necrosis Factor-alpha (TNF-α)] and excessive activation of glial cells (Vayanakkan et al., 2024). This evidence concerns the gene IL6 and depressive symptom measurement.